EDGAR Filing Documents for 0001104659-21-121280

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001104659-21-121280

Filing Date

2021-09-30

Accepted

2021-09-30 17:05:11

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POS AM	tm2128760-4_posam.htm	POS AM	713047
2	EXHIBIT 23.1	tm2128760d4_ex23-1.htm	EX-23.1	4521
3	GRAPHIC	tm2128760-4_posamsp1img001.jpg	GRAPHIC	13860
4	GRAPHIC	tm2128760d4_posomsp7img1.jpg	GRAPHIC	13727
	Complete submission text file	0001104659-21-121280.txt		757079

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: POS AM | Act: 33 | File No.: 333-233048 | Film No.: 211295699
SIC: 2834 Pharmaceutical Preparations